{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:52:41Z","timestamp":1770965561460,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s15010-013-0511-2","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T22:40:06Z","timestamp":1374705606000},"page":"207-210","source":"Crossref","is-referenced-by-count":16,"title":["Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia"],"prefix":"10.1007","volume":"42","author":[{"given":"F.","family":"Pea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Crapis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cojutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"511_CR1","doi-asserted-by":"crossref","first-page":"iii15","DOI":"10.1093\/jac\/dkn368","volume":"62","author":"RA Seaton","year":"2008","unstructured":"Seaton RA. Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008;62:iii15\u201323.","journal-title":"J Antimicrob Chemother"},{"key":"511_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-012-0018-5","volume":"52","author":"JA Roberts","year":"2013","unstructured":"Roberts JA, Pea F, Lipman J. The clinical relevance of plasma protein binding changes. Clin Pharmacokinet. 2013;52:1\u20138.","journal-title":"Clin Pharmacokinet"},{"key":"511_CR3","first-page":"5","volume":"8","author":"F Pea","year":"2013","unstructured":"Pea F. Plasma pharmacokinetics of antimicrobial agents in critically ill patients. Curr Clin Pharmacol. 2013;8:5\u201312.","journal-title":"Curr Clin Pharmacol"},{"key":"511_CR4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/cc7774","volume":"13","author":"F Pea","year":"2009","unstructured":"Pea F, Viale P. Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock\u2014does the dose matter? Crit Care. 2009;13:214.","journal-title":"Crit Care"},{"key":"511_CR5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","volume":"32","author":"CH Wong","year":"2004","unstructured":"Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535\u201341.","journal-title":"Crit Care Med"},{"key":"511_CR6","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1345\/aph.1P745","volume":"45","author":"F Pea","year":"2011","unstructured":"Pea F, Cojutti P, Sbrojavacca R, Cadeo B, Cristini F, Bulfoni A, et al. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. Ann Pharmacother. 2011;45:e37.","journal-title":"Ann Pharmacother"},{"key":"511_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ejvs.2006.03.003","volume":"32","author":"PA Coughlin","year":"2006","unstructured":"Coughlin PA, Mavor AI. Arterial consequences of recreational drug use. Eur J Vasc Endovasc Surg. 2006;32:389\u201396.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"511_CR8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00270-008-9440-3","volume":"32","author":"AN Keeling","year":"2009","unstructured":"Keeling AN, McGrath FP, Lee MJ. Interventional radiology in the diagnosis, management, and follow-up of pseudoaneurysms. Cardiovasc Intervent Radiol. 2009;32:2\u201318.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"511_CR9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1128\/AAC.00738-06","volume":"51","author":"LI Mortin","year":"2007","unstructured":"Mortin LI, Li T, Van Praagh AD, Zhang S, Zhang XX, Alder JD. Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria. Antimicrob Agents Chemother. 2007;51:1787\u201394.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AAC.48.1.63-68.2004","volume":"48","author":"N Safdar","year":"2004","unstructured":"Safdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother. 2004;48:63\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","volume":"47","author":"BH Dvorchik","year":"2003","unstructured":"Dvorchik BH, Brazier D, DeBruin MF, Arbeit RD. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother. 2003;47:1318\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1128\/AAC.36.5.1109","volume":"36","author":"MJ Rybak","year":"1992","unstructured":"Rybak MJ, Bailey EM, Lamp KC, Kaatz GW. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia. Antimicrob Agents Chemother. 1992;36:1109\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/AAC.27.3.285","volume":"27","author":"CH King","year":"1985","unstructured":"King CH, Creger RJ, Ellner JJ. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs. Antimicrob Agents Chemother. 1985;27:285\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.35.4.696","volume":"35","author":"MJ Rybak","year":"1991","unstructured":"Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, et al. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother. 1991;35:696\u2013700.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1996.tb15977.x","volume":"119","author":"J Gutkowska","year":"1996","unstructured":"Gutkowska J, Schiller PW. Renal effects of TAPP, a highly selective mu-opioid agonist. Br J Pharmacol. 1996;119:239\u201344.","journal-title":"Br J Pharmacol"},{"key":"511_CR16","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/AAC.00090-07","volume":"51","author":"S Lemaire","year":"2007","unstructured":"Lemaire S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. Antimicrob Agents Chemother. 2007;51:2748\u201357.","journal-title":"Antimicrob Agents Chemother"},{"key":"511_CR17","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/652767","volume":"50","author":"SM Bhavnani","year":"2010","unstructured":"Bhavnani SM, Rubino CM, Ambrose PG, Drusano GL. Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis. Clin Infect Dis. 2010;50:1568\u201374.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0511-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0511-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T17:38:06Z","timestamp":1559497086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0511-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}